TRUSOPT (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the TRUSOPT drug offered from Merck Sharp & Dohme Corp.. This Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | dorzolamide hydrochloride |
| SUBSTANCE NAME: | DORZOLAMIDE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1994-12-09 |
| END MARKETING DATE: | 0000-00-00 |
TRUSOPT HUMAN PRESCRIPTION DRUG Details:
| Item Description | TRUSOPT from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 1994-12-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-3519_0ab2a390-2925-4b2c-98d3-24f338eee2c2 |
| PRODUCT NDC: | 0006-3519 |
| APPLICATION NUMBER: | NDA020408 |
Other DORZOLAMIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
